Similar Items: Advancing Germline Genetic Testing for Breast Cancer in Resource-Restricted Settings: Evidence, Barriers, and a Practical Roadmap for Implementation
- Pathogenic germline variants identified in pNEN patients during genetic testing
- Advances in the Treatment of Breast Cancer at Different Stages of Pregnancy
- Intelligent nano‐platforms in breast cancer therapy: Current advances and future perspectives
- Molecular and genomic advances in breast cancer: A comprehensive review of predictive and therapeutic innovations
- Abemaciclib in HR+, HER2− Breast Cancer: A Narrative Review of the Clinical Evidence
- Women’s health across the reproductive lifespan in women with germline TP53 pathogenic variants: a clinical perspective